Toh et al. (2011) evaluated the inhibitory effects of G-Rk1 (0.25 μg/ml) on cell growth of liver cancer cell lines (human hepatocellular carcinoma cells (HepG2), SNU449, and SNU182). Here, GRK1 is linked to hepatocellular carcinoma.